Renal function may be monitored, particularly if patients experience significant gastrointestinal adverse effects that could lead to dehydration
For example, one study showed that in people with type 2 diabetes, treatment with semaglutide (1 mg weekly) causes an average loss of about 6% of body weight over 40 weeks, while treatment with tirzepatide (15 mg/week) leads to an 11% weight loss in this population
and take a deep breath Image content: This image is available to view online
Preliminary studies suggest that liposomes optimize absorption by protecting the GSH from oxidation
If you're new to semaglutide, wait until your dose is stable and you've adapted to the medication before reintroducing trigger snacks, allowing your body to signal true tolerance versus early-phase side effects
Transition to 10mg vials once you reach the 1.0mg weekly dose level